Tradestie Institutional Equity Comparison Engine
PSAI vs AHG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AHG Overall Edge
AHG Captures Institutional Edge (1โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Akso Health Group ADS (AHG) driven by superior Growth & Margin while PSAI counters with relative strength in Momentum & Technical. Fundamentally, PSAI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AHG at N/M Forward P/E and -28.9% operating margin (-12.9% YoY). In options structure, PSAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AHG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PSAI N/M vs AHG N/M Fwd P/E
Growth & Margin Winner
AHG
Op Margin N/A vs -28.9% ยท YoY N/A vs -12.9%
Momentum & Technical Winner
PSAI
1Y +14.3% vs -15.3% ยท 52W Pos 91% vs 36%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
PSAI
US Equity
PSAI
Institutional Equity
$29.30
-0.86% 1D
Market Cap
N/A
1M Return
+1.91%
1Y Return
+14.29%
Forward P/E
N/M
Unified AI Score
54.8 / 100
HOLD
Tech 55.0
Fund 56.0
Flow 50.0
Mom 41.1
AHG
NASDAQ
Akso Health Group ADS
Services-Business Services, Nec
$1.33
+7.26% 1D
Market Cap
$1.1B
1M Return
-1.48%
1Y Return
-15.29%
Forward P/E
N/M
Unified AI Score
42.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PSAI +14.29%
AHG -15.29%
Spread: +49.41 pp (PSAI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PSAI TTM Op. Margin: N/A
AHG TTM Op. Margin: -28.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PSAI vs AHG. Trailing 12-month operating profitability (PSAI N/A vs AHG -28.9%) and valuation multiples (PSAI N/M vs AHG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PSAI | AHG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $1.1B | Larger Scale | AHG |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | -12.9% | Higher Growth | AHG |
| Operating Margin (TTM) Profitability | N/A | -28.9% | Higher Margin | AHG |
| Net Profit Margin Profitability | N/A | -135.0% | Higher Margin | AHG |
| Return on Equity (ROE) Capital Efficiency | N/A | -9.8% | Higher ROE | AHG |
| 52-Week Range Position Momentum | 91% ($25โ$30) | 36% ($1โ$2) | Stronger Trend | PSAI |
| Beta / 30D Volatility Risk Regime | 0.80ฮฒ ยท 13% Vol | 0.16ฮฒ ยท 97% Vol | Lower Realized Risk | PSAI |
| Unified Institutional Score Composite Signal | 54.8 / 100 (HOLD) | 42.6 / 100 (HOLD) | Higher Composite | PSAI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PSAI vs AHG Buy Guide
PSAI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AHG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PSAI nor AHG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.